1,913
Participants
Start Date
June 30, 2000
Primary Completion Date
October 31, 2001
Study Completion Date
December 31, 2001
Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live
A single 0.5 mL subcutaneous injection at Day 0
Comparator: Tripedia
A single 0.5 mL intramuscular injection (at Day 0 or Day 42)
Comparator: Comvax
A single 0.5 mL intramuscular injection (at Day 0 or Day 42)
Comparator: Varivax
A single 0.5 mL subcutaneous injection at Day 0
Comparator: M-M-R II
A single 0.5 mL subcutaneous injection at Day 0
Merck Sharp & Dohme LLC
INDUSTRY